Study reveals long-term effectiveness of therapy for common cause of kidney failure

New research provides support for the long-term efficacy of a drug used to treat in patients with autosomal dominant polycystic kidney disease (ADPKD), a common cause of kidney failure. The findings appear in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN). The hormone vasopressin promotes the progression of ADPKD, the fourth leading cause of […]

Continue reading »

Risk of cochlear disorders up with history of migraine

(HealthDay)—The risk of cochlear disorders, especially tinnitus, is increased among patients with a history of migraine, according to a study published online July 12 in JAMA Otolaryngology-Head & Neck Surgery. Juen-Haur Hwang, M.D., Ph.D., from the Dalin Tzu Chi Hospital in Taiwan, and colleagues used claims data from the Taiwan Longitudinal Health Insurance Database 2005 to identify 1,056 patients with […]

Continue reading »

Hand-holding, stress ball don’t cut anxiety in skin CA removal

(HealthDay)—Hand-holding and squeezing a stress ball do not provide anxiety reduction among patients during excisional removal of non-melanoma skin cancer, according to a study published online July 18 in JAMA Dermatology. Arianna F. Yanes, from Northwestern University in Chicago, and colleagues conducted a randomized trial involving 135 adults who required excisional removal of non-melanoma skin cancer of the head or […]

Continue reading »

Five-year stroke rates lower after PCI versus CABG

(HealthDay)—Stroke rates are lower at 30 days and five years after percutaneous coronary intervention (PCI) than after coronary artery bypass grafting (CABG), according to a study published in the July 24 issue of the Journal of the American College of Cardiology. Stuart J. Head, M.D., Ph.D., from Erasmus Medical Center in Rotterdam, Netherlands, and colleagues conducted a collaborative individual patient-data […]

Continue reading »

Compound identified that protects against neurodegeneration

Researchers from the University of Liverpool have identified a new compound that protects against neurodegeneration in nematode worms. The discovery may enable novel treatments for human neurodegenerative diseases to be developed in the future. With the predicted growth of the global ageing population, cases of age-associated neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS) are […]

Continue reading »
1 300 301 302 303 304 387